Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Marimed (MRMD) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Marimed (MRMD) over the last 15 years, with Q3 2025 value amounting to $14.8 million.

  • Marimed's Operating Expenses fell 435.97% to $14.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.7 million, marking a year-over-year decrease of 169.06%. This contributed to the annual value of $60.0 million for FY2024, which is 1634.26% up from last year.
  • As of Q3 2025, Marimed's Operating Expenses stood at $14.8 million, which was down 435.97% from $14.9 million recorded in Q2 2025.
  • Marimed's Operating Expenses' 5-year high stood at $16.0 million during Q1 2025, with a 5-year trough of $6.1 million in Q1 2021.
  • Its 5-year average for Operating Expenses is $12.6 million, with a median of $13.5 million in 2023.
  • Per our database at Business Quant, Marimed's Operating Expenses soared by 29907.93% in 2021 and then crashed by 1094.7% in 2022.
  • Quarter analysis of 5 years shows Marimed's Operating Expenses stood at $14.3 million in 2021, then decreased by 10.95% to $12.7 million in 2022, then rose by 17.16% to $14.9 million in 2023, then decreased by 5.57% to $14.1 million in 2024, then increased by 4.89% to $14.8 million in 2025.
  • Its Operating Expenses was $14.8 million in Q3 2025, compared to $14.9 million in Q2 2025 and $16.0 million in Q1 2025.